82.1 F
San Fernando
Tuesday, May 28, 2024

Amgen reports slight rebound in ’08

Amgen Inc. just missed some Wall Street targets for the quarter and the year but overall rode through 2008 well after undergoing a major restructuring in 2007. The company faces further challenges for what was once its top drug even as it prepares to bring a potential blockbuster drug to market. For the full story click here

Featured Articles

Related Articles